Apr 10, 2024, 05:50
The Innovation Oncology – Loss-of-Function properties of mutant TP53 are critical for a broad range of cancer cells
The Innovation Oncology shared on X/Twitter:
”Loss-of-Function, but Not Gain-of-Function properties of mutant TP53 are critical for the proliferation, survival, and metastasis of a broad range of cancer cells.”
Read further.
Source: The Innovation Oncology/X
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Feb 5, 2025, 20:42
Feb 5, 2025, 20:41
Feb 5, 2025, 20:38
Feb 5, 2025, 20:35
Feb 5, 2025, 17:53